Why Biogen Stock Is Trading Down Today – Biogen (NASDAQ:BIIB)

Biogen Inc. (NASDAQ: BIIB) shares fell Tuesday after it was deemed that the ability of the company’s Alzheimer’s drug, Leqembi, to slow cognitive decline may not outweigh its risks, according to European experts considering the potential use of it.